Stocks
Heron Therapeutics (HRTX) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -284.5% | -1 341% | 325.4% | 40.4% | -140.9% | -338.6% | ||
| Changes by years, y/y, % | -188pp | -1 057pp | +1 667pp | -285pp | -181pp | +8.0% | |||
Heron Therapeutics. ROE, %
Heron Therapeutics. ROE, changes, pp
Heron Therapeutics (HRTX) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | 27.4% | 3.42% | -91.2% | -140.9% | -338.6% | -338.6% | |
| Changes by years, y/y, % | -212pp | -123pp | -161pp | -181pp | -366pp | |||
| Changes by quarters, q/q, % | -13pp | -24pp | -95pp | -50pp | -198pp | |||
